DOI: https://doi.org/10.21203/rs.2.11195/v1
In parallel with the rapid growth of the aged population, the incidence of degenerative spinal disorders is rising2-4. The demand for surgical procedure to manage degenerative spinal disease, especially spinal decompression, also has increased in the elderly1-3. However, geriatric patients undergoing lumbar spinal decompression may be at risk of adverse postoperative events, such as infection, cardiac and pulmonary complications, which in turn contribute to functional decline, nursing home admission, and even death4 5.
Intraoperative goal-directed fluid therapy (GDT) is a method to optimize fluids and inotrope use though monitoring hemodynamics during operations6 7. GDT has been reported effective in improving the cardiac index and oxygen delivery and consumption in septic patients. In abdominal and thoracic surgery much evidence documents that perioperative GDT lowers lactic acid values, reduces the frequency of cardiac and pulmonary complications, and shortens hospital stay11-12. A small sample size cohort study showed that application of a GDT in major spine surgery is feasible and can lead to reduced blood losses and transfusions13. However, no randomized controlled trials (RCTs) have been conducted to show the evidence of benefit from GDT in postoperative complications in patients undergoing orthopedic surgery, especially in spine surgery, in prone positions.
In this study, we have conducted a randomized clinical trial to determine if the use of GDT during lumbar decompressive surgery in the prone position improves outcomes and the rate of complications in an elderly population.
This was a single-center, parallel-group RCT conducted at Peking Union Medical College Hospital, a class A tertiary comprehensive hospital. Ethical permission was obtained from the Ethical Committee of Peking Union Medical College Hospital (ZS-1290). All patients were instructed about benefits and risks of the study and each participant signed an informed consent form. The trial is registered at www.clinicaltrials.gov (NCT02470221).
Patient Population
Patients admitted to the Department of Orthopedics of Peking Union Medical College Hospital (PUMCH) with the confirmed diagnosis of degenerative spinal stenosis, and who had indication for decompressive surgery under general anesthesia, were enrolled from March 1, 2017 to September 30, 2017. Inclusion criteria were age > 60, American Society of Anesthesiologists score II-III, and expected duration of operation > 2 h. Patients with severe cardiac arrhythmia (which would affect the accuracy of stroke volume variation as an indicator of fluid responsiveness), vascular disease (which would prohibit radial artery cannulation), and mental disorder were excluded.
Randomization
Patients were assigned to one of the two groups (control group and GDT group) using a computer-generated randomization scheme. Allocation concealment was obtained using number labeled opaque envelopes that were opened just before the surgery. Patients were excluded from analysis if any of the following events occurred: vascular access line could not be established; LiDCO cardiac output monitor (LiDCO Ltd, Cambridge, UK) failed to calibrate; or the plan of surgery or anesthesia was changed. Data were collected by persons unaware of treatment allocation.
Intraoperative Management and Monitoring
All patients who received surgical decompression for lumbar spinal stenosis under general anesthesia were managed according to our national guidelines. Thus, after induction, patients were placed in the prone position supported by 4 pads (2 pads under the shoulders and 2 under pelvic sites) to suspend the chest and abdomen from the operation bed. A LiDCO monitor, calibrated according to the manufacturer’s instructions, recorded stroke volume, cardiac output and systemic vascular resistance during anesthesia. All patients were monitored intra- and post-operatively according to currently recommended standards to maintain arterial oxygen saturation of hemoglobin (SaO2) >96%, hemoglobin (>80 g/L), core temperature (>36.5°C) and heart rate (50-100/min). Ringer’s lactate was administered at 3 ml/kg/h for maintenance of fluid balance. Additional fluid was administered at the discretion of the attending anesthesiologist, based on patients’ pulse, arterial pressure, urine output, core-peripheral temperature gradient, serum lactate, and base excess. A dose of 6 mg ephedrine or 50 μg phenylephrine was given when fluid boluses failed to keep the systolic arterial pressure >90 mm Hg or mean arterial pressure (MAP) >65 mmHg. If such episodes occurred, they were recorded as hypotensive events. Patients in both groups also received a dose of 4 mg ondansetron as a prophylactic antiemetic during induction. Postoperative analgesia was provided with intravenous morphine infusion.
Goal-directed Fluid Therapy
Patients in the GDT group received the fluid management depicted in Figure 1. This protocol was based on the Frank-Starling mechanism of the heart. Fluid maintenance was set at 3-5 ml/kg/h of normal saline. Optimal stroke volume (SV) was maintained with targeted crystalloid boluses given as indicated according to invasive continuous hemodynamics monitoring. If MAP dropped more than 30%, or stroke volume variation (SVV) was more than 13%, boluses of 3 ml/kg (Figure 1) were given and SV response recorded. If a response was recorded (SV increase >10%), another bolus was given. If no response was recorded (SV was not elevated by more than 10%), no further bolus was given unless the SV decreased by 10%. Vasopressor or inotrope was not administered unless the MAP dropped persistently.
Anesthesiologist-directed Fluid Therapy (control group)
Patients in the control group received conventional fluid therapy, decided by the attending anesthesiologists based on the patient’s hemodynamic condition and responses, to maintain MAP >65 mm Hg, heart rate 50-100 bpm, and urine output >0.5 ml/kg/h.
Outcomes
The primary outcome of interest was the postoperative complications from admission to the operating theatre to 30 days after the surgery, include nausea and vomiting, infectious complications, delayed wound healing, cardiac events and kidney disorders .
The secondary outcomes of interest was the change of lactic acid concentrations throughout the perioperative period and intraoperative fluid balance. Arterial blood gas (ABG) and lactic acid were measured at 7 predefined times: T0, 24 h before surgery; T1, beginning of the operation; T2, 1h after the operation began; T3, 2h after the operation began; T4, end of the operation surgery; T5, discharge from the post-anesthesia care unit; and T6, 24 h after surgery.
Statistical Analysis
The primary endpoint of the study was the concentration of lactate acid in the perioperative period. In a previous report, the average lactate concentration during the operative period was 2.015± 0.986 mmol/l8. We expected that a difference of 0.50 mmol/l in lactate concentration would be clinically meaningful. Therefore, we estimated that a total of 66 patients (33 in each group) would be needed to detect a difference with a power of 90% (α=0.05). Considering missing data or loss of follow up, we enrolled 40 patients in each arm. Data were analyzed on an intention-to-treat basis. Changes of lactate over time were tested with repeated-measure analysis of variance (ANOVA). The primary outcome data were normally distributed after reciprocal transformation and analyzed with the t-test. Categorical data were tested with Chi-square test and Chi-square test for trend. Data are presented as mean ± standard deviation when normally distributed. A p value of 0.05 was considered significant. All data were analyzed with SPSS (IBM SPSS Statistics v24, IBM, Armonk, NY, USA).
Patient Enrollment
104 patients were screened, and 88 patients were enrolled and randomly assigned to either the control group (43) or the GDT group (45) (Figure 2 consort flow diagram). After excluding patients who did not receive the allocated intervention or were lost to follow-up (radial artery cannulation was failed in 2 patients in GDT group, and one patient was lost to follow up, one patient was found to have atrial fibrillation before the induction in control group) 41 control patient and 43 GDT patients were analyzed. Patients’ demographics, comorbidities, duration of anesthesia, length of operation, and other variables were similar between the two groups (Table 1).
Fluid Administration and Balance
Perioperative fluid balance in the control and GDT groups are listed in Table 2. The volumes of crystalloid and total volumes of intravenous fluids administered were significantly more in the GDT group than in the control group. The volumes of intraoperative colloid, number of patients who received blood transfusion, amounts of blood transfused, volume of blood loss, urine output, and total output volumes were not significantly different in the two groups.
Perioperative Lactate
The concentrations of lactic acid during the perioperative period are illustrated in Table 3. Values in the control group and the GDT group were similar at T0 (24 h before operation). Thereafter, values rose in the control group and were significantly higher than in the GDT group from T2 (1 h after the operations began) until T6 (24 h after the operations concluded). The differences were greatest at T5 (discharge from the post-anesthesia care unit (control, 2.50 ± 1.22 mmol; GDT, 1.32 ± 0.42; p 0.001). Values in the GDT group did not change appreciably through the perioperative period. A lactic acid concentration of >2 mmol/l is defined as hyperlacticaemia. This value was exceeded in 25% of control patients at T5 compared with 7% GDT patients (p<0.001).
Hemodynamic variation
The variation of hemodynamics during the surgery are different in two groups. The monitor parameter CO (caridic output) of G group is higher than that of group C, with statistically significant difference in T4 ( the end of the operation surgery, P<0.05 Figure 3.)
Postoperative Outcomes
Postoperative outcomes of the GDT and control group are listed in Table 4. The most common complication is nausea and vomiting without significant difference between the two groups (P>0.05). GDT patients had fewer infectious complications (including fever, pulmonary infection, urinary infection) that did control patients (4.7% vs. 19.5%, P<0.001). Delayed wound healing occurred in 2 patients in the control group, but no patient occurred in the GDT group (P<0.001).
In this randomized controlled trial of GDT during lumbar decompressive surgery under general anesthesia the most important finding was a significantly lower concentration of lactic acid in patients who received GDT than in those who received anesthesiologist-directed anesthesia. Total volumes of intravenous fluids administered in the perioperative period also were significantly more in the GDT group. Associated outcomes were a lower incidence of infections and postoperative complications in the GDT group. To our knowledge, this is the first study in which LiDCO-based GDT was used during lumbar surgery with prone position in elderly patients. LiDCO monitoring allowed the administration of fluid in response to changes in SVV measured in real time.
Ideally, a simple, affordable, and reliable method to improve intraoperative fluid management would be available for routine use. Esophageal Doppler has been used to guide fluid management. However, its use is partially limited by the need for experienced staff, and it is not optimal for monitoring patients in the prone position. Hence, we used LiDCO monitoring, which has been extensively evaluated in clinical use for more than 10 years9.
The prone position can affect heart-lung interaction by decreasing right ventricular pre-load and compliance of the respiratory system. Lumbar decompressive surgery in the prone position is a major orthopedic operation that may have substantial blood loss, transfusion requirement, and fluid shifts. In patients, especially elderly patients, undergoing these operations, optimized intraoperative fluid management is important for organ perfusion and limiting postoperative complications. Biais et al10. found that prone positioning induces a significant increase in SVV (supine position vs. prone position, 10% vs.14%) but does not alter the ability to predict fluid responsiveness. Elderly patients might be more sensitive to prone position and ventricular pre-load change. Thus, we used an SVV of 13% for patients in the prone position as thresholds for hypovolemia to target volume administration.
Blood lactate concentrations and severity of microvascular alterations are strongly correlated, and lactate concentrations can reliably reflect the adequacy of tissue perfusion and oxygenation11 12. Lactate values above 2 mmol/L indicate hyperlactatemia. Most instances of excessive accumulation of lactate are due to tissue hypoperfusion caused by problems such as hypovolemia, cardiac failure, sepsis, or cardiopulmonary arrest13 14. Tissue hypovolemia or hypoxia during surgery, forcing aerobic metabolism of glucose, leads to production of lactic acid exceeding its removal, with resultant adverse outcomes. Our finding that blood lactate concentrations progressively increased with conventional anesthesia in patients undergoing spinal operation indicates that they developed tissue hypoperfusion. Our study also showed that GDT is a valid method to optimize hemodynamics and oxygen delivery during the high-risk orthopedic surgery for elderly patients.
In 2012, Gao15 et al. reported that individual GDT could decrease the incidence of hyperlactatemia in elderly patients operated for abdominal cancer. In a retrospectively controlled study, GDT decreased the time for lactate clearance in open- abdominal surgery patients8, and similar results were found in elderly patients16. A recent study had conflicting results, perhaps because of shorter operative times and lower-risk procedures17. Several studies have found intimate associations between elevated lactate levels and worse outcomes in major high-risk surgery18-20, and non-clearers of lactate (below the median level of lactate clearance) have had a higher 30-day mortality rate than have clearers21. Early lactate clearance is associated with biomarkers of inflammation, coagulation, apoptosis, organ dysfunction and mortality during operation and intensive care units22. In our study, lactic acid concentrations were predictors of outcomes. GDT optimized perfusion during surgery and decreased concentrations of lactic acid, with associated improved outcomes.
Another difference between the GDT and control group in this study was in fluid management; the GDT group received more fluid than did the control group. The control group was given fluid according to local hospital standard practice to maintain desired blood pressure, heart rate and urine output. There are little data for comparison of surgical outcomes based on fluid administration. Srinivasa23 et al. reported that patients in a GDT protocol group received 2.5 L compared with 1.5 L in a restrictive-fluid group during rectal surgery. Myles et al30 recently enrolled 2983 patients at high risk for complications undergoing major abdominal surgery to compare restrictive and liberal fluid therapy. There was no difference in the rate of disability-free survival between these two fluid regimen. However, restrictive fluid therapy was associated with a higher rate of acute kidney injury at 30 days after surgery. Variability in fluid volume may simply reflect the ability of clinicians to adjust fluid administration to individual patient needs; therefore, the local hospital standard protocol may result in suboptimal fluid administration during surgery. We believe that GDT better enables anesthesiologists to give the right amount of fluid at the right time, and thereby improve perfusion.
We also found a lower incidence of postoperative complications, especially for infections, in patients who received GDT24-26. In an early study of 100 high-risk surgical patients, GDT was associated with improved outcomes, a finding that was supported by more recent studies with GDT aimed at optimizing intraoperative oxygen delivery in high-risk patients27. Recent studies and meta-analyses have reported also that perioperative GDT was associated with a lower incidence of surgical-site infections28 29, but some studies30 31 have reported opposing views regarding postoperative complications, meta-analyses have found a decrease in mortality and length of hospital stay in patients receiving GDT after major surgery, but the studies may have been flawed by the inclusion of highly heterogeneous studies. The debate about the benefits of GDT in high-risk patients is unresolved, and additional quality studies are needed, perhaps initially with study of improvement in stroke volume management.
Limitations of the study
Our study has limitations. First, the sample size might have been inadequate to detect significant differences in some complications. Second, in our study we didn’t analyze differences in nausea and vomiting with detail, which may lead diverse result in other study. Further studies will be needed to clarify the direct impact of a GDT protocol on complications in a larger prospectively enrolled population.
Conclusions
The use of goal-directed fluid therapy compared with conventional fluid therapy in elderly patients undergoing lumbar stenosis decompression in the prone position was associated with lower concentrations of lactic acid and postoperative complications. It is reasonable that the favorable outcomes of goal-directed therapy were due to optimal fluid management and better perfusion of tissues and organs.
GDT: goal-directed fluid therapy; RCTs: randomized controlled trials; MAP: mean arterial pressure; SV: stroke volume; SVV: stroke volume variation; ABG: arterial blood gas; CO: caridic output
Ethics approval and consent to participate
This study was approved by the Ethics Committee of Peking Union Medical College Hospital(ZS-1290), and the protocal was registered at the ClinicalTrials (NCT02470221). Initial registration date was 06/09/2015. All procedures performed in this study involving human participants were in cordance with the Ethical Standards of the Institutional Ethics Committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. All patients signed writtern informed consent before surgery.
Consent for publication
Not applicable.
Availability of data and material
The datasets used and/or analysed during the current study available from the corresponding author on reasonable request.
Competing interests
The authors declare that they have no competing interests.
Funding
Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences (2016-12M-3-024), part of the fund is used in design of the study and collection. Braun Research Fund for the science of anesthesia (BBDF-2016-001), which contribute to analysis and interpretation of date.
Authors’ contributions
Study conception: L.X.
Study design, study coordination data analysis, manuscript preparation: L.X., D.X., Y.H.
Patient recruitment: D.X., X.L.,
Data collection: L.X., D.X., X.L.
Data analysis: L.X., D.X.
Manuscript review: Y.H.
All authors reviewed the results and approved the final version of the manuscript.
Acknowledgements
Not applicable.
Table 1 Patient characteristics
|
Control group (n=41) |
GDT group (n=43) |
P value |
|
Age (yr) |
68.0±6.3 |
68.7±6.0 |
0.687 |
|
Sex (Male/Female) |
15:26 |
19:24 |
0.503 |
|
BMI (kg/m2) |
25.3±3.9 |
25.4±3.8 |
0.614 |
|
Comorbidity |
|
|
|
|
None |
7 (17%) |
10 (23%) |
0.481 |
|
CAD |
8 (20%) |
6 (14%) |
0.494 |
|
DM |
6 (15%) |
8 (19%) |
0.494 |
|
HTN |
22 (54) |
21 (49%) |
0.659 |
|
Tumor |
0 (0%) |
0 (0%) |
1 |
|
Other |
10 (24%) |
11 (26%) |
0.900 |
|
ASA I II III length of anaesthesia (min) |
207.7±56.1 3 34 4 |
200.7±54.6 3 39 1 |
0.924 1 0.824 0.325 |
|
Length of surgery (min) |
174.8±51.9 |
165.4±52.0 |
0.849 |
|
Vital sighs baseline |
|
|
|
|
MAP |
97.0±11.2 |
94.3±10.5 |
0.439 |
|
HR |
80.2±11.2 |
76.3±9.0 |
0.268 |
|
T |
36.5±0.3 |
36.5±0.4 |
0.365 |
|
Lab examination baseline |
|
|
|
|
WBC(×109/L) |
6.6±1.9 |
5.8±1.5 |
0.429 |
|
HGB (g/L) |
135.0±15.4 |
134.4±14.0 |
0.421 |
|
HCT (%) ALT(U/L) Cr(mmol/l) |
39.8±4.6 34.2±5.6 76±8.7 |
40.8±7.0 32.1±5.4 82±5.6 |
0.763 0.734 0.675 |
|
Table 2 the fluid management
I.V. fluid (ml) |
Control group (n=41) |
GDT group (n=43) |
P value |
Intraoperative (crystalloid) |
1500±330 |
1851±388 |
0.001 |
Intraoperative (colloid) |
368±276 |
386±325 |
0.789 |
Number of patients transfused |
17 |
17 |
1 |
Amount of blood transfusion |
167±271 |
178±303 |
0.865 |
Total volume of i.v. fluid |
2036±424 |
2415±539 |
0.001 |
Bleeding |
344±210 |
351±171 |
0.852 |
Urine |
554±367 |
566±394 |
0.879 |
Total volume of output |
897±476 |
910±469 |
0.905 |
Table 3 the perioperative lactate level (mmol/l)
|
Control group (n=41) |
GDT group (n=43) |
P value |
Before surgery |
|
|
|
T0 24h before surgery |
1.49±0.48 |
1.41±0.47 |
0.413 |
Surgery |
|
|
|
T1 at the beginning of the surgery |
1.49±0.72 |
1.35±0.45 |
0.205 |
T2 1h after the initial of the surgery |
1.52±0.71 |
1.21±0.47 |
0.005 |
T3 2h after initial of the surgery |
1.71±0.89 |
1.25±0.49 |
0.002 |
T4 Time ending of surgery |
1.92±0.99 |
1.30±0.59 |
0.012 |
T5 Time leaving the PACU |
2.50±1.22 |
1.32±0.42 |
0.001 |
After surgery |
|
|
|
T6 24h after surgery |
1.90±0.76 |
1.28±0.49 |
0.005 |
Table 4 the result of complications and lab examination
|
Control group (n=41) |
GDT group (n=43) |
P value |
|
|
Postoperative Nausea and Vomiting(%) |
13 (31.7%) |
12 (27.9%) |
0.703 |
|
|
Infection sepsis pulmonary infection urinary infection |
8 (19.5%) 1 3 2 |
2 (4.7%) 1 0 1 |
0.001 |
|
|
wound infection |
2 |
0 |
|
|
|
Cardiac events Acute kidney injury |
0 0 |
0 0 |
|
|
|
Number of patients developing one or more complications |
21 (51.2%) |
12 (27.9%) |
0.001 |
|
|
|
|
|
|
||
Cardiac events: myocardial infarction; arrhythmia; cardiogenic pulmonary edema; need evidence of clinical findings, cardiac enzymes, ECG changes